PharmaLeaders

02/19/2026

Discover the most important AI trends, risks and opportunities, practical takeaways you can use now. Download your free whitepaper for exclusive insights from CSL, Roche, Teva Pharmaceuticals, and more.

Our latest industry whitepaper ‘Prove Impact: How Ethical AI Drives Revenue, Retention, and Reputation in Healthcare’ will help you cut through the noise surrounding AI. Access your copy now!

https://1.reutersevents.com/lp=39146?extsource=6903eloquawhitepaper1form_mediapartner_21jan26_acmscompany_social_1&utm_campaign=6903eloquawhitepaper1form_mediapartner_21jan26_acmscompany_social_1&utm_medium=mediapartner&utm_source=acmscompany

11/21/2025

The FDA wants to cut prescription drug costs by fast-tracking biosimilars (cheaper generics for biologics). Great news for your wallet!

But the U.S. Patent Office (USPTO) is making it nearly impossible for these companies to challenge the legal patents that block them from launching.

This bureaucratic clash is the key reason cheaper drugs stay off the market for years.

Find out how the "patent thicket" is defeating the FDA's cost-saving efforts. 👇

🔗 https://pharmaleaders.com/biosimilar-boom-on-hold-fdas-plan-confronts-patent-office-resistance/

The Food and Drug Administration (FDA) is taking major steps to speed up the approval and reduce the

10/30/2025

Drug discovery just got the biggest AI boost ever! 🤯

Eli Lilly and NVIDIA are building the pharma industry’s most powerful AI supercomputer—an "AI factory" set to drastically speed up finding new medicines.

See how this massive alliance will transform healthcare: 🔗 READ MORE https://pharmaleaders.com/eli-lilly-and-nvidia-forge-alliance-to-build-ai-drug-discovery-supercomputer/

Eli Lilly and tech giant NVIDIA have partnered on an ambitious plan to build what they claim will be

09/16/2025

AI is no longer a futuristic concept in drug discovery—it's here. This article explores how AI is revolutionizing the pharmaceutical industry, from accelerating research to the challenges of "hallucinations" in data.

Read the full story to learn how AI is shaping the future of medicine: https://pharmaleaders.com/how-ai-will-shape-the-future-of-drug-discovery/

08/28/2025

💊 Is the biopharma industry in trouble? 🤔 New data shows a significant surge in layoffs this year, with job cuts already surpassing last year's totals. Major players like Merck, Bayer, and Moderna are all making big changes.

Why are so many biopharma companies cutting staff? This article breaks down the key drivers, from failed clinical trials and expiring patents to new regulatory pressures.

Read more to understand what's behind this new wave of layoffs and what it means for the industry's future. 👇https://pharmaleaders.com/a-new-wave-of-biopharma-layoffs/

The biopharma industry is experiencing a notable surge in layoffs this year, with job cuts in 2025 a

07/21/2025

📢 Massive transition underway in drugmaking! Our latest article dives into how AI is moving from "fringe to frontier" in biopharma, becoming a core tool in drug discovery and development.

Featuring insights from Dr. Lynda Stuart of FFST, Dr. Mathai Mammen of Parabilis Medicines, and Matt Truppo of Sanofi, we explore:
🔬 How AI is drastically cutting research times
💡 Overcoming resistance to adopting new tech
⚖️ Balancing rapid innovation with responsible use and ethics

It's an exciting, complex time for the industry. Learn how leaders are navigating this shift and building for a future where human insight and AI's capabilities are integrated for better patient well-being. Visit https://pharmaleaders.com/ai-in-biopharma-navigating-the-massive-transition-in-drugmaking-leadership/ to learn more.

From Fringe to Frontier: AI as a Core Tool Dr. Lynda Stuart, CEO of the Fund for Science and Technol

06/18/2025

The pharma industry is under the microscope for drug costs. 🔍 Where can they find efficiencies without sacrificing new drug development?

Our new article explores insights from Jim Kremidas on optimizing clinical trials, emphasizing both operational improvements and the critical role of human expertise.

Read more below.

05/14/2025

The ReImagine Pharma Marketing 2025 Conference is YOUR chance to connect with industry leaders 🤝 and discover new strategies to enhance your marketing efforts 📈. Don't miss this unique opportunity to experience executive-level content, innovative solutions, and exclusive networking opportunities tailored for Pharma professionals. As a VIP Attendee at ReImagine Pharma, you get complimentary registration, access to an opening night reception on May 19, 2025, two complimentary nights at the hotel for May 19-20, + access to two unique networking opportunities. More info here: https://pharmaleaders.com/event/reimagine-pharma-marketing-east-2025/

04/15/2025

From our editor, James Miller: "Pharma USA 2025 in Philadelphia was a fantastic blend of learning and networking. Gained valuable insights into real-world strategies and connected with some brilliant minds in commercial, medical affairs, and beyond." Learn more by reading his article at https://pharmaleaders.com/pharma-usa-2025-where-industry-leaders-shaped-the-future/

05/01/2024

Are you following the latest in Pharma News? Recent topics include Innovations in AI & Life Sciences, Boosting Marketing Strategy, Developing Deeper Patient Journey Insights, and more. https://pharmaleaders.com/category/pharma-news/

04/04/2024

PharmaLeaders was an enthusiastic media partner for Pharma USA and enjoyed learning from the amazing presenters. The conference offered a truly panoramic view of the challenges and opportunities defining the pharmaceutical industry’s future. From the imperative of innovation and the nuances of policy and pricing to the transformative potential of personalization, data integration, and digital technologies, the discussions underscored a collective mission: to advance healthcare in ways that are truly patient-centric. Read about our key takeaways at

The Pharma USA 2024 conference in Philadelphia brought together more than 1200 industry leaders, hea

01/05/2024

PharmaLeaders is excited to be a media partner for CES 2024. Will we see you there? We're most excited about covering the Digital Health Summit and will bring you content in the coming weeks! CES 2024 — the world’s largest consumer technology trade show — runs Jan. 9-12 in Las Vegas. Health and wellness as a category has had a growing presence at CES and is a very prominent part of the overall experience. We’re starting to see the lines between regulated medical devices and health, wellness, lifestyle devices converge. Learn more at https://pharmaleaders.com/event/ces-2024/